At the Association of Biomolecular Research Facilities annual meeting this week, the ABRF Genomics Research Group presented results from its comparison of single-cell RNA sequencing platforms.
The one-year projects aim to create computational tools, algorithms, visualizations, and benchmark datasets for use with Human Cell Atlas data.
The team's approach discovered cell-essential and human embryonic stem cell-essential genes in karyotypically stable human pluripotent stem cells
The companies will integrate Agilent's Seahorse XFe96/XFe24 Analyzers with BioTek's Cytation 1 Cell Imaging Multi-Mode Reader.
The company plans to launch a single-cell CNV assay, a single cell ATAC-seq assay, and a single-cell feature barcoding assay later this year.
The company has yet to release formal studies, but discussed two cases that illustrate the potential benefit of the methodology in improving patient treatment.
The firm plans to expedite cell sorting for research labs with an inexpensive device that uses piezoelectric actuators and disposable microfluidics.
Evotec will gain non-exclusive rights to Ncardia IP, including a broad panel of stem cell-derived cell lines for use in drug target discovery and testing.
The firm will use the proceeds to develop its cell-sorting technology for cell line development, genomic sample preparation, CRISPR gene editing, and antibody discovery.
Harvard Bioscience will offer Fluxion's BioFlux and IonFlux cellular analysis platforms to its North American customers.
Labcyte and the University of Helsinki's Institute for Molecular Medicine Finland have expanded their partnership to include multiple new applications.
The company believes its system, launched earlier this year, can outperform other microfluidic technologies, yielding samples with fewer white blood cells that allow better genomic analyses.
The NIH has awarded $169 million this year to support 110 new projects in the Brain Research through Advancing Innovative Neurotechnologies Initiative.
Such an atlas could enable investigators to understand how genetic variants impact disease risk, define drug toxicities, improve therapies, and advance regenerative medicine.
The funding is being awarded under the auspices of the NIH's BRAIN Initiative Cell Census Network, which aims to establish reference cell atlases of the brain.
Gyros Protein Technologies will distribute Euro Diagnostica's reporter gene cell lines in Europe and North America.
The companies will offer CDI's human induced pluripotent stem cell-derived tissue cells with Nanion's ion channel drug discovery and screening platform.
The Ann Arbor-based biotech startup will use the funding to develop its microbubble technology that allows for removal of biomolecules from biological samples.
The company also received a grant from the Maryland Innovation Initiative to help advance the device toward commercialization.
Separately, FlowJo and Cytapex Bioinformatics said they have partnered to provide bioinformatics consulting and services for flow cytometry data analysis.
British Nobel laureates and Fields Medal winners warn that a 'hard' Brexit could harm science across the UK, the Guardian reports.
Vox reports on inequities in genetic research and efforts to address them.
The New York Times reports that Arizona State University's Lawrence Krauss is retiring following allegations of sexual misconduct.
In PNAS this week: de novo NUS1 mutations linked to Parkinson's disease risk, candidate hepatocellular carcinoma drivers, and more.